BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32213034)

  • 1. Albumin: Indications in chronic liver disease.
    Tufoni M; Zaccherini G; Caraceni P; Bernardi M
    United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    European Association for the Study of the Liver
    J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
    [No Abstract]   [Full Text] [Related]  

  • 3. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
    ;
    Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
    Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
    Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines on the management of ascites in cirrhosis (2023 version)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):813-826. PubMed ID: 37723063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N; Sanyal AJ
    Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management and nursing care of cirrhotic ascites.
    Sargent S
    Br J Nurs; 2006 Feb 23-Mar 8; 15(4):212-9. PubMed ID: 16603988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites and spontaneous bacterial peritonitis: an Asian perspective.
    Lee JM; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1494-503. PubMed ID: 19743995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ascites--a sign of death?].
    Nordin A; Mäkisalo H
    Duodecim; 2000; 116(19):2074-83; quiz 2084, 2165. PubMed ID: 12017728
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cirrhosis and ascites.
    Ginès P; Cárdenas A; Arroyo V; Rodés J
    N Engl J Med; 2004 Apr; 350(16):1646-54. PubMed ID: 15084697
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome.
    Khan S; Linganna M
    Cleve Clin J Med; 2023 Apr; 90(4):209-213. PubMed ID: 37011958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
    Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
    Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese guidelines on the management of ascites and its related complications in cirrhosis.
    ; Xu X; Duan Z; Ding H; Li W; Jia J; Wei L; Linghu E; Zhuang H
    Hepatol Int; 2019 Jan; 13(1):1-21. PubMed ID: 30656520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of refractory ascites and hepatorenal syndrome.
    Sussman AN; Boyer TD
    Curr Gastroenterol Rep; 2011 Feb; 13(1):17-25. PubMed ID: 21080246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.